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GENUS MELALEUCA: PHYTOCHEMISTRY, PHARMACOLOGY AND EFFECT
AGAINST COVID-19
Abstract
Medicinal plants are used for the prevention and treatment of many diseases as they are rich in
phytochemical constituents (like terpenes, flavonoids, and alkaloids) responsible for the pharmacological
effects of these plants. Genus Melaleuca named the tea tree, belonging to the family Myrtaceae, is
cultivated in Australia as well as in the Pacific and some regions of Asia. It has been employed in
Australian traditional medicine for its broad antimicrobial activity because of its contents of phenolic
compounds, monoterpenes, tannins, flavonoids, sesquiterpenes, and essential oils. Owing to the valuable
uses of plants of genus Melaleuca, for different medical purposes, it was deemed interest to summarize
the previous studies reported from 2004 to 2020 in the available literature about the phytochemistry and
pharmacological potential of both volatile and non-volatile components of Melaleuca species. Accordingly,
this article may help researchers work on plants of genus Melaleuca to promote clinical applications
towards the development of novel drugs of diverse pharmacological activities, including inhibitory effects
on COVID 19 obtained from Melaleuca species.
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Melaleuca, phytoconstituents, essential oil, Myrtaceae, polyphenols, pharmacological activities, COVID 19
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1. INTRODUCTION
Traditional medicine plays a crucial role within the health system of both urban and rural
populations due to many reasons: availability, accessibility, cultural and traditional beliefs, and
sometimes affordability as per the WHO global report on traditional medicine 2019. Around 80%
of the world population use traditional medicine to satisfy their primary healthcare need (Ngbolua,
2018). The pharmacological potential of many plant species is due to the presence of
phytochemicals like saponins, glycosides, tannins, alkaloids, flavonoids, terpenes that have
played a vital role in the discovery of new pharmaceutical molecules (Batiha et al., 2020). Many
research groups have focused on developing synthetic, or semi-synthetic analogs of those
phytochemical compounds and this helped to better understand the mechanism of the action of
molecules through structure-activity relationship studies with the aim of developing new effective
drugs (Tringali, 2020). Myrtaceae family known also as the myrtle present in Queensland, New
South Wales, consists of around 3000 species and 140 genera. The family is abundant in Australia
but is also distributed in tropical and subtropical regions. Plants of family Myrtaceae are shrubs
to big trees. The leaves are opposite, leathery, simple, glandular-dotted, and evergreen. Seeds do
not have endosperm. This family is split into two subfamilies Leptospermoideae and Myrtoideae
(Ngbolua, 2018). It is one of the most promising plant families, due to its value and
pharmacological potential in traditional medicine (Laribi et al., 2020). Genus Melaleuca, named
tea trees or paperbark trees, have spiral leaves. Its name, tea tree, is being after the sailor James
Cook drunk this herb rather than tea during his journey to Australia in 1770 (Bar, 2020).
Melaleuca is a large genus belonging to the Myrtaceae family consisting of 290 species
indigenous to New Zealand, Australia, New Guinea, Papua, Indonesia, Solomon Islands,
Vietnam, Thailand, Cambodia, Malaysia, and Myanmar. Cultivation of Melaleuca started in
Australia then extended to increase the essential oil production. The most favorable habitat is the
Coastal region preferably in a moist soil environment and filled with sun. These species are
resistant and may support different environmental conditions like drylands, acidic soil, flooded
soil, or saline soil, but cannot tolerate extremely low temperatures. Plants of Genus Melaleuca
are small trees or tall shrubs that possess spiral leaves that are hairless with glands rich in aromatic
oil, and to gather the oil at the time of harvest the entire plant is eradicated from 6 to 18 months.
The flowers are in clusters or spike, the flowering begins early at periods and intensity that varies
among species. The seeds have a testa with an embryo but without endosperm (Bar, 2020; Brophy
et al., 2013; Sharifi-Rad, Salehi, et al., 2017). Melaleuca is familiar as an aromatic medicinal plant
because of its beneficial essential oil rich in hydrocarbon and oxygenated monoterpenoids,
sesquiterpenes, and phenolic compounds having potent anti-oxidant, anti-inflammatory and
antimicrobial effects (Sharifi-Rad, Salehi, et al., 2017). The oil production output is high in some
species as M. alternifolia and M. cajuputi and small in others as M. quinquenervia. Large leaves
species such as M. cajuputi and M. quinquenervia produce respectively the cajuput oil and niaouli
oil. These oils were reported beneficial for many medicinal uses like intestinal problems as
worms, toothache, headache, bronchitis, and laryngitis, in addition to its insecticidal effect.
Furthermore, the leaves of these plants are used in Australia for fever, congestion, influenza after
crushing the leaves and inhaling its vapor. Tea tree oil (TTO) is the oil of terpinen-4-ol type
extracted from some Melaleuca species mainly from M. alternifolia. This oil has a strong
antimicrobial potential. The tea tree oil is found in many cosmetic products as shampoos,
sunscreens, and various skin products for microbial infections. Moreover, the blossom of the
genus Melaleuca produces honey of great value (Bar, 2020). It is also utilized in skin infections
like scabies, herpes, and acne. Several clinical studies proved the effect of tea tree oil against
athlete’s foot. Thai traditional medicine showed the potential of Melaleuca alternifolia against
acne, and that of Melaleuca alternifolia and M. leucadendron for the treatment of psoriasis in
South America. The efficacy of tea tree oil extracted from Melaleuca alternifolia was proved in a
comparative study of its effect versus erythromycin and Aloe vera (Mazzarello et al., 2018).
Besides the importance of essential oil in Genus Melaleuca, the non –volatile components in this
plant are of great value being reported for its antiparasitic, antimicrobial, antioxidant,
neuroprotective, anti-inflammatory antihistaminic anticancer, hepatoprotective, antischistosomal
activities. The reported articles were done either on the crude extract of the plant or on the isolated
compounds among which the anticancer potential that was studied on betulinic acid obtained from
the Melaleuca plant and was vital in anti-cancer drug development (Bar, 2020). Taiwan folk
medicine has also used the barks and leaves of M. leucadendron as a tranquilizer, sedative, for
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pain relief, and for gout treatment in Vietnam. Many other remedies were recorded for the relief
of headaches, vertigo, rheumatism, and convulsions in Indonesia. The leaves were proved useful
for hyperlipidemia and obesity in Indonesia. In the Philippines and Cuba, this species was
evaluated against malaria, dermatitis, respiratory disorders, and inflammation in Senegal folk
medicine. M.quinquenervia was reported as a repellant for gastrointestinal disorders in Thai
medicine. M.cajuputi was also recorded as an antimicrobial (Sharifi-Rad, Salehi, et al., 2017).
Non-volatile components in Melaleuca are mainly terpenoids and phenolic compounds. The plant
phenolics are formed of phenylpropanoids, flavonoids, polyphenols, and free phenolic acids.
Triterpenoids which are plant metabolites having important pharmacology, are of various
skeletons like derivatives of lupine, ursane, and oleanane. This plant is also rich in flavonoids that
were highly investigated in literature for their various pharmacological actions. They include
flavonols, flavans, and flavones. The dominant group is flavonol and is characterized by the
presence of methyl esters. Additionally, several flavonoid glycosides were reported together with
glucose, rhamnose, glucuronic acid, and xylose. Hydrolysable tannins with a potent antioxidant
effect are also phytochemicals present in the non-volatile part of Melaleuca like oligomeric
ellagitannins, gallitannins. Miscellaneous compounds like minor alkaloids, naphthalene were also
isolated from the non-volatile parts of Melaleuca (Bar, 2020). This article aims to describe the
phytochemistry and the pharmacological importance of both volatile and non-volatile parts of
Genus Melaleuca belonging to the family Myrtaceae, in addition, it highlights the structure
activity relationships of the most promising species. This manuscript was achieved with the help
of google scholar and Pubmed to collect the data published in monographs and articles dated from
2000 to 2020. Phytochemistry of Melaleuca species The previously isolated compounds from
different Melaleuca species were identified by GC (Gas Chromatography), HPLC (HighPerformance Liquid Chromatography), UV, MS (Mass Spectrometer), and NMR (nuclear
magnetic resonance), and are presented in tables 1,2, and 3.
Table 1: A presentation of the most promising Melaleuca species
Melaleuca species

Illustration

Nature of the oil/oil yield

Ref.

M.styphelioides

-Sesquiterpenoid: caryophyllene oxide
(22-26%) and staphulenol (18-20%)
-small amounts of monoterpenes (αpinene,1.8cineole, p-cymene)
-oil yield is little less than 0.1%

(Al-Sayed
et al., 2020;
Ferdaous
Albouchi et
al., 2018;
Brophy et
al., 2013)

M.
alterrnifolia

-Three chemotypes
1- the main commercial
chemotype contained
terpinen-4-ol. This was
accompanied by significant
amounts of a-terpinene and
g-terpinene.
2- Chemotype II contained 1,8cineole (25–90%) and
associated monoterpenes.
3- Chemotype III contained
terpinolene (40–55%) as its
principal component.
-Oil yield 3-6%

(Brophy et
al., 2013;
Farag et al.,
2004;
Sandner et
al., 2020)

M.cajuputi

1,8-cineole (15–60%), limonene (1–
5%), viridiflorene (0.5–7%), aterpineol (1–7%), globulol (0.2–8.0%),
viridiflorol (0.2–10.0%), spathulenol
(0.4–30.0%) and b-caryophyllene (1–
4%)
Oil yield is 0.4–1.2%.

(Brophy et
al., 2013;
Bua et al.,
2020;
Rattanaburi
et al., 2013)

https://digitalcommons.bau.edu.lb/hwbjournal/vol4/iss2/2
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M.armillaris

monoterpenes. The principal
component was 1,8-cineole (66–73%)
Sesquiterpenes contributed little to the
oil, with the most prominent members
being b-caryophyllene (1–3%),
aromadendrene (0.2–2.0%), d-cadinene
(0.7–2.0%) and Globulol (0.3–2.0%).
-oil yield 0.1–0.3%.

(Brophy et
al., 2013;
Farag et al.,
2004;
Siddique et
al., 2017)

M.leucadendra

-three chemotypes
1-Chemotype I contained methyl
eugenol (94–98%), with insignificant
amounts of E-methyl isoeugenol (<1%)
2-Chemotype II contained E-methyl
isoeugenol (27–90%, the majority
>70%), with lesser amounts of methyl
eugenol (6–25%)
3-The western provenances produced
an oil (chemotype III) that contained
1,8-cineole (10–45%), p-cymene (5–
22%), a-pinene (4–19%), limonene (3–
6%) and a-terpineol (trace–9%)
The oil yield of the aromatic
chemotypes I and II (dry weight, w/w)
was 1.0–2.5%, while that from the
terpenoid chemotype, chemotype III,
was 0.1–0.5%.

(Brophy et
al., 2013;
Farag et al.,
2004)

M.ercifolia

Monoterpenic
Chemotypes were not really present but
there was a distinct association between
oil composition and latitude. The more
northerly provenances of this species
were rich in linalool, while the more
southerly provenances were rich in 1,8cineole
Oil yield 0.8–2.0%

(Brophy et
al., 2013;
Farag et al.,
2004)

Table 2. Chemical composition of the essential oils extracted from the fresh leaves of five Melaleuca
species (Elmi et al., 2019; Farag et al., 2004)
Area percentage
M.

M.

alternifolia

ericifolia

M.
leucadendron

M.
armillaris

styphelioides

4.4

0.12

4.24

0.02

1.53

–

–

–

–

9.65

2.15

0.36

64.3

33.93

0.59

1-Dodecen-3-yne

–

–

–

–

3.26

1-Tetradecene

–

–

0.25

–

–

2,4-Dodecadienal

–

–

–

–

0.73

2-Nonenal

–

–

–

–

0.63

3-Decyne

–

–

–

–

1.9

1.38

–

–

–

2.24

Benzaldehyde

–

–

0.29

–

–

Caryophyllene
oxide

0.76

–

–

–

43.78

Identified
constituents
α-Pinene
(-) Spathulenol
1,8-Cineole

Aromaddendrene
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Area percentage
M.

M.

alternifolia

ericifolia

M.
leucadendron

M.
armillaris

styphelioides

cis-Pinene hydrate

–

–

–

0.04

–

cis-Piperitol

–

–

–

0.14

–

D-Elemene

–

–

–

0.21

–

D-Germacrene

–

–

–

0.24

–

Elemicin

–

0.08

–

–

–

Estragol

–

0.26

–

–

–

Eugenol

–

0.07

–

0.09

–

Geraniol

–

–

–

0.06

–

Ledol

–

–

1.2

–

2.82

1.78

–

6.7

2.61

–

Linalool

–

–

0.1

0.67

–

Methyl eugenol

–

96.84

–

–

–

0.03

–

–

6.59

–

–

–

0.16

0.43

–

Terpinen-4-ol

41.49

–

0.82

18.79

2.39

Terpinolene

3.18

–

0.16

2.03

–

Terpinyl acetate

–

–

–

3.09

–

trans Alphadehydroterpineol

–

–

–

0.28

–

Valencene

–

–

3.91

–

–

α-Cadinene

–

–

–

0.29

–

α-Eudesmol

–

–

0.15

–

–

α-Terpinene

9.59

–

–

5.8

–

α-Terpineol

4.42

–

11.02

3.49

1

α-Thujene

–

–

–

1.52

–

β -Eudesmol

–

–

0.17

–

–

β -germacrene

–

–

–

0.29

–

β -Myrcene

0.72

–

0.65

2.28

–

β -Pinene

0.03

0.17

1.67

1.35

–

–

0.28

–

–

–

γ -Terpinene

20.55

–

0.57

10.37

0.61

γ -Terpineol

–

–

0.25

–

–

ρ -Cymene

3.66

–

0.3

0.59

0.83

Identified
constituents

Limonene

Sabinene
tans-pinene hydrate

γ -Elemene

https://digitalcommons.bau.edu.lb/hwbjournal/vol4/iss2/2
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Table 3. Flavonoids isolated previously from the genus Melaleuca
Compound
1
2
3
4
5

Name
Apigenin
Apigenin-7-methyl ether
Apigenin-7,4`-dimethyl ether
Herbacetin-3-O-glucuronide
5-Hydroxy-7,4`-dimethoxy6,8-dimethylflavone

Plant/Part

Reference

Leaves of M. huegelii

(Wollenwebe
r et al., 2000)

Leaves of M. squarrosa
Leaves of M. cajuputi

Leaves of M. huegelii

6

Kaempferol

Leaves of M. leucadendron
Leaf and stem of M. quinquenervia
Leaves of M. ericifolia

7
8
9

Kaempferol-3-methyl ether
Kaempferol-3,7-dimethyl
ether
Kaempferol-3,7,4`-trimethyl
ether

Leaves of M. huegelii
Leaves of M. huegelii
Leaves of M. huegelii

10

Kaempferol-3-O-glucoside

Leaves of M. leucadendra

11

Kaempferol-3-O-xylosyl(1```2``) -glucoside

Leaves of M. ericifolia
Leaves of M. ericifolia

12

Kaempferol -3-O-rhamnoside
Leaves of M. styphelioides

13
14

Kaempferol-3-O-(2``-Ogalloyl)-glucuronide

Leaves of M. squarrosa
Leaves of M. huegelii

Luteolin
Honey of M. quinquenervia

15

Luteolin-7,3`-dimethyl ether

Leaves of M. huegelii

16

Miquelianin

Leaves of M. leucadendra

17

Myricetin

Leaves of M. leucadendra

18

Myricetin 3-O-(2``-Ogalloyl)-α-rhamnopyranoside

Leaves of M. quinquenervia
Leaves of M. leucadendra

19

Myricitrin
Leaves of M. ericifolia
Leaves of M. quinquenervia

20

Myricetin 3-O-β-D-glucoside
Leaves of M. leucadendra

21

Myricetin 3-O-β-Dglucuronide

Leaves of M. quinquenervia

22

Myricetin 3-O-rhamnoside

Leaves of M. leucadendra

23

Myricetin 3-rutinoside

Leaves of M. leucadendra

Published by Digital Commons @ BAU, 2022

(Bar, 2020)
(Rattanaburi
et al., 2013)
(Wollenwebe
r et al., 2000)
(Bar, 2020)
(Goetz &
France,
2012)
(Bar, 2020)
(Wollenwebe
r et al., 2000)
(Wollenwebe
r et al., 2000)
(Wollenwebe
r et al., 2000)
(Bar, 2020)
(Bar, 2020)
(Bar, 2020)

(Al-Sayed,
El-Lakkany,
et al., 2014)
(Bar, 2020)
(Wollenwebe
r et al., 2000)
(Bar, 2020)
(Wollenwebe
r et al., 2000)
(Bar, 2020)
(Bar, 2020)
(Bar, 2020)
(Bar, 2020)
(Bar, 2020)
(Bar, 2020)
(Hashim et
al., 2018)
(Bar, 2020)
(Hashim et
al., 2018)
(Hashim et
al., 2018)
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Compound
24
25

Name
Myricetin-3-O-β-4C1galactopyranuronoid
Myricetin 3-O-xylosyl(1```2``)-glucoside

Plant/Part
Leaves of M. leucadendra
Leaves of M. ericifolia
Leaves of M. huegelii
Leaves of M. leucadendra

Quercetin

Leaf and stem of M. quinquenervia

Reference
(Hashim et
al., 2018)
(Bar, 2020)
(Wollenwebe
r et al., 2000)
(Hashim et
al., 2018)
(Bar, 2020)

26
Leaves of M. ericifolia
27

Quercetin-3-methyl ether

Leaves of M. huegelii

28

Quercetin-3,7-dimethyl ether

Leaves of M. huegelii

29
30
31

Quercetin-3,7,3`-trimethyl
ether
Quercetin-3,7,4`-trimethyl
ether
Quercetin-3-O-xyloglucoside

Leaves of M. huegelii
Leaves of M. huegelii
Leaves of M. leucadendra

Leaves of M. leucadendra

Leaf and stem of M. quinquenervia
32

Quercetin

Leaves of M. ericifolia
Leaves of M. cajuputi

33
34

Quercetin-7-O-(6``-galloyl) -D-glucopyranoside
Quercetin-3-O-xylosyl(1```2``) -glucoside

Leaves of M. quinquenervia
Leaves of M. ericifolia

35

Quercetin-3-O-galactoside

Leaves of M. ericifolia

36

Quercetin-3-O-glucoside

Leaves of M. ericifolia

37

Quercetin-3-rutinoside, rutin

Leaves of M. leucadendra

38

5,7,3`,4`-Tetrahydroxyflavone
2`-O--D-glucuronide

Leaves of M. quinquenervia
Leaves of M. ericifolia

Leaves of M. leucadendra
39

(Wollenwebe
r et al., 2000)
(Wollenwebe
r et al., 2000)
(Wollenwebe
r et al., 2000)
(Wollenwebe
r et al., 2000)
(Hashim et
al., 2018)
(Hashim et
al., 2018)
(Bar, 2020)
(Bar, 2020)
(Rattanaburi
et al., 2013)
(Bar, 2020)
(Bar, 2020)
(Bar, 2020)
(Bar, 2020)
(Hashim et
al., 2018)
(Bar, 2020)
(Bar, 2020)

(Hashim et
al., 2018)

Tricetin

Honey of M. quinquenervia

40

(Bar, 2020)

Catechin

https://digitalcommons.bau.edu.lb/hwbjournal/vol4/iss2/2
DOI: https://www.doi.org/10.54729/KMCI3389
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al., 2018)

6

kanso et al.: GENUS MELALEUCA: PHYTOCHEMISTRY, PHARMACOLOGY AND EFFECT AGAINST COVID-19

Compound

Name

Plant/Part

41

Kryptostrobin

flowers of M. quinquenervia

42

Leucadenone A

Leaves of M. leucadendra

43

Leucadenone B

Leaves of M. leucadendra

44

Leucadenone C

Leaves of M. leucadendra

45

Leucadenone D

Leaves of M. leucadendra

46

Melanervin

Flowers of M. quinquenervia

47

Strobopinin

Flowers of M. quinquenervia

Reference
(Bar, 2020)

(Bar, 2020)
(Bar, 2020)
(Bar, 2020)
(Bar, 2020)
(Bar, 2020)
(Bar, 2020)

This literature review on the phytochemistry of genus Melaleuca revealed the presence of
47 flavonoids, 30 hydrolysable tannins, a variety of other phenolic compounds, and triterpenoids
in the non-volatile part of Melaleuca in addition to many active constituents in the essential oil
mainly sesquiterpenes ( oxygenated sesquiterpenes as Globulol, viridiflorol) ,sesquiterpene
hydrocarbons as aromadendrene, δ-cadinene), monoterpenes (oxygenated monoterpenes as
terpineol, 1.8 cineole) and monoterpene hydrocarbons as ( sabinene, limonene, p-cymene),
phenolics such as (eugenol). Oxygenated monoterpenes also referred to as terpenes and
oxygenated sesquiterpenes are referred to as terpenoids(Sharifi-Rad, Sureda, et al., 2017). These
phytochemical constituents are responsible for the diversity in the pharmacological potential of
Melaleuca.

2. PHARMACOLOGICAL ACTIVITIES
2.1 Antimicrobial Potential
The literature survey showed a broad antimicrobial potential of Melaleuca, some
species are antibacterial, others are potent antiviral or antifungal. The antifungal potential of
Melaleuca was reported in a study that compared the in vitro antifungal effect between
volatile and non-volatile extracts of Melaleuca styphelioides leaves and the activity was
proven against Penicillium digitatum, Rhizopus nigricans, and Aspergillus niger. around 10
components of the oil were isolated with eugenol the principal one (87,2%). The analysis
was done using Gas Chromatography (GC). The samples tested have shown a difference
within the level of selectivity of the microorganisms, the leaves oil was potent against
A.niger, and also the most susceptible species for the aqueous extract was P.digitatum
(IC50=9,54 mg/ml) while R.nigricans was the foremost vulnerable to the methanolic
extract(IC50=8,31mg/ml) therefore the volatile oil, methanolic and aqueous extracts of
Melaleuca styphelioids leaves have antifungal potential thus it is often used as an alternative
to chemical preservatives in food and pharmaceutical industries (Bar, 2020; Laribi et al.,
2020).
Another study was done on the oil of Melaleuca styphelioides in vitro on eight selected
microorganisms by the assay of both MBC (Minimal Bactericidal Concentration) and MIC
(Minimum Inhibitory Concentration) and also the broth dilution method, the results showed
high antimicrobial activity for the oil against S. epidermidis(Sharifi-Rad, Salehi, et al., 2017)
In conclusion, different Melaleuca species showed a potential antimicrobial activity such as
M.ercifolia and M.leucadendron against Aspergillus niger and Bacillus subtitles and a strong
antiviral potential (Farag et al., 2004).M alternifolia activity was proved against Tobacco
mosaic virus in Nicotiana glutinosa (Farag et al., 2004), in addition to a potential against
various bacteria and fungus such as S. aureus and E. coli, S. mutans, L. monocytogenes,
Porphyromonas gingival, Porphyromonas endodontalis, Pseudomonas aeruginosa, Candida
albicans, Aspergillus niger, and Candida glabrata (Cordeiro et al., 2020; Wińska et al.,
2019).
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Other Melaleuca species such as M.Linarrifolia, M. fulgens, M. alternifolia, M.
armillaris and M. bracteata showed a broad-spectrum antibacterial effect against gram
positive and gram -negative bacteria (Li et al., 2018; Padalia et al., 2015; Siddique et al.,
2017).M. leucadendra showed also a wide potential against Leishmania amazonensis,
Trypanosoma brucei, Microsporum canis, Plasmodium falciparum, Trypanosoma cruzi,
Leishmania infantum, T. brucei. parapsilosis, E. faecalis, S. aureus, M. canis, P. aeruginosa,
E. coli, M. canis, C. albicans (Bautista-Silva et al., 2020; Zhang et al., 2019).

2.2 Antioxidant and Anti-Inflammatory Activities
The antioxidant effect was reported in articles that proved the antioxidant potential of
methanolic extract of leaves of Melaleuca styphelioides using FRAP, DPPH, ABTS+ assays,
pro-inflammatory mediators like nitric oxide synthase (iNOS), cyclooxygenase 2 (COX2),
nuclear factor kappa B, and intercellular adhesion molecule-1 in interferon-gamma/histamine
inflammation-induced human NCTC 2544 keratinocytes. The analysis was done by LC/MSMS technique to spot and quantify the components and by Western blot and RT-PCR to assess
the anti-inflammatory potential. The results showed that the methanolic extract has the best
level of phenols like ellagic acid, quercetin, so it has a strong anti-inflammatory and
antioxidant potential, it's also beneficial for the treatment of inflammatory skin diseases
(Ferdaous Albouchi et al., 2018)
Further assays performed on ellagitannins isolated from Melaleuca styphelioides by
the generation of f/MLF/CB induced anion and also the release of elastase by human
neutrophils, the results showed a powerful antioxidant effect and also a heme reducing
property that may be helpful within the development of heme reducing drugs, additionally to
the reduction in elastase release by 90,2% which reflects a high anti-inflammatory effect by
direct inhibition of inflammatory enzyme activity(Al-Sayed et al., 2020) Moreover, one
among the reported studies that isolated pedunculagin, tellimagradinI, pterocarinin A, and
casuarinin from Melaleuca styphelioides leaves, the compounds were identified by 1D and
2D NMR, HRESI-MS/MS, and UV data. The study aimed to demonstrate the renoprotective
activity of the isolated compounds in glucose and oxalate challenged NRK-49F cell model,
the evaluation of the isolated constituent’s antioxidant effect was done on the idea of their
effect on lipid peroxidation levels and antioxidant enzymes activities. The results showed
potential antioxidant and cytoprotective properties in oxidative stress-mediated kidney
damage, additionally, the phenolic compounds demonstrated a nephroprotective role in
urinary diseases and diabetes mellitus (Ganesan et al., 2018).

2.3 Anti-Allergic Effects
The anti-allergic potential was studied on ellagitannin isolated from Melaleuca
styphelioides using MTT viability assay, ellagitannin reduced the viability of rat basophilic
leukemia cells by 31,3% and suppressed 20,3% of ᵦ-hexosaminidase induced with calcium
ionophore so it was proved to possess anti-allergic activity at a level of 10µM (Al-Sayed
et al., 2020).

2.4 Hepatoprotective Potential
The synergistic antioxidant, hepatoprotective potential was also measured on
methanolic extract of Melaleuca styphelioides leaves in CCL4 induced liver injury in mice,
using DPPH radical scavenging assay and monitoring the level of antioxidant enzymes
(GST, SOD, GR, and GPx) additionally to the level of AST, ALT, ALP within the serum
and levels of SOD (superoxide dismutase), GSH (glutathione), GPx (glutathione
peroxidase), GR (glutathione reductase), GST (glutathione S transferase) and MDA
(malondialdehyde) in liver homogenate. Identification of MSE was done by UV, NMR,
and HRESI-MS/MS data. The results showed that the MSE (M.styphelioides extract)
increased the antioxidant enzymes and GSH (glutathione) levels (29 and 57%) compared
with the CCL4-treated groups, histological results showed improvement within the status
of the liver, in cell degeneration necrosis and cell infiltration(Al-Sayed, El-Lakkany, et al.,
2014) further article showed that the hepatoprotective potential of the methanolic extract of
Melaleuca styphelioides was mainly attributed to tellimagrandin I,II, pentagalloyl glucose
and pedunculagin in an in-vitro study in CCL4-challenged HepG2 cell model(Al-Sayed &
Esmat, 2016). More studies were done to evaluate the hepatoprotective and antioxidant
potential on the ellagitannin isolated from the methanolic extract of Melaleuca styphelioides
https://digitalcommons.bau.edu.lb/hwbjournal/vol4/iss2/2
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by measuring ALT (alanine aminotransferase) and AST (aspartate aminotransferase) in a
culture of HepG2 cells challenged with CCL4, the subsequent parameters were evaluated
MDA, GSH, SOD for hepatoprotective effect and also the DPPH radical scavenging assay
for antioxidant activity measurement. Results demonstrated a decrease in ALT, AST levels,
and a rise in antioxidant enzymes, so Melaleuca styphelioides contains hepatoprotective
components like silymarin, ellagitannin, and its derivative rhoipteleanin H a potent antielastase agent thus this may be promising within the development of medicine for elastaserelated inflammatory conditions (Al-Sayed et al., 2020).

2.5 Molluscicidal and Antischistosomal Activity
The biocidal effect was proved on the isolated compounds pedunculagin, casuarinin,
kaempferol-3-O- α –rhamnoside from the methanolic extract of Melaleuca styphelioides
leaves, the structure of the isolates was detected by 1D and 2D NMR, HRESI –MS/MS data
and Ultra-Violet spectroscopy these compounds showed a moderate biocidal effect against
Biomphalaria Alexandrina snails in several stages of the life cycle so this is often very
promising within the discovery of antischistosomal drugs within the future(Al-Sayed,
Hamid, et al., 2014)

2.6 Anti-Acanthamoeba effect
The antiparasitic potential of the subsequent isolated components isolated from the
volatile oil extracted of the Melaleuca styphelioides leaves which were identified by gas
chromatography-mass spectrometry (GC-MS) :Caryophyllene oxide (23,42%), Ledol
(5,98%), Isoaromadandrene epoxide (7,45%), Spathulenol (20,5%), Isopinocarveol(2,18%)
and α -pinene(3,82%).The data showed that the oil may be a potent anti-amoeba since it
inhibits the expansion of Acanthamoeba castellanii Neff by an IC50 of 69,03+9,17µg/ml,
but this was proven in vitro only so further studies on the toxicity of volatile oil on human
macrophages and in vivo studies are needed (Ferdaous Albouchi et al., 2017).

2.7 Aphidicidal Activities
A reported study was done on the oil of M.styphelioides against insect pests, Aphis
gossipi, Myzus persicae, and Aphis spiraecola infecting citrus trees.GC/MS was used to
determine the oil chemical composition and therefore the following components were
identified staphulenol (20,5%) and caryophyllene oxide( 23,42%), isoaromadendrene
epoxide (7,45%),isopenocarveol (2,18%), ledol (5,98%) and α-pinene (3,82%).The results
showed a potent fumigant and cell toxicity against the pest species so it may be helpful in
the development of recent strategies for agriculture production to use of M.styphelioides oil
as fumigant insecticide against citrus aphids adults and nymphs(F. Albouchi et al., 2018;
Ikbal & Pavela, 2019)

2.8 Chemosensitizing Properties
A study evaluated the chemosensitizating effect of CRYO which is a sesquiterpene
isolated from the essential oil of M. styphelioides, the results showed the benefit from using
CRYO at non-toxic dose together with sorafenib since it increases the intracellular
accumulation of the drug in hepatocellular cancer cells. So, this phytochemical proved a
potential to improve synergistically the cytotoxic power of chemotherapeutic medicines(Di
Giacomo et al., 2019).

2.9 Inhibitory Activity against COVID-19
Moreover, the great interest in Melaleuca pushed 15 authors to evaluate the inhibitory
effect of M. cajuputi oil against COVID-19 by docking stimulation technique. They proved
that the following active components in the essential oil have an anticoronavirus potential
in the following order Terpineol (TA2), Guaiol (TA5), Linalool (TA19), Cineol (TA1),
βSelinenol (TA3), α-Eudesmol (TA4), γ-Eudesmol (TA7). These phytochemicals attack
synergistically the PDB6LU7 protein found in the SARS-COV-2 and inhibit its host
receptor the ACE2 protein so, the authors concluded that this oil is beneficial in the
prevention of COVID-19 spread (My et al., 2020).
Some other pharmacological activities of different Melaleuca species are
summarized in table 4
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Table 4: Pharmacological potential of some Melaleuca species
Melaleuca species

M.stypheliodes

Isolates
I-Antioxidant and anti-inflammatory

Leaves extract: Phenols (like ellagic acid,
quercetin) Ellagitannins, pedunculagin,
tellimagradinI, pterocarinin A, and casuarinin

M. leucadendron

Essential oil : eugenol methyl ether

M. fulgens

Essential oil: eugenol methyl ether

M. bracteata

Essential oil: eugenol methyl ether

M.armillaris

Essential oil : eugenol methyl ether

M. cajuputi

M.squarrosa

M. quinquenervia
M.leucadendra

Leaves and barks: β-triketone flavanone hybrids,
cajuputones A–C (1–3)
Ellagitannins : squarrosanins A, B, and C
Flavonoïdes : kaempferol-3-O-(2-O-galloyl) glucuronide, herbacetin-3-O-glucuronide
C-glucosidic tannins
Niaouli essential oil
Ethanolic extract of Leaves: myricetin 3-O-β-4 C1
-galactopyranuronoid

References
(Al-Sayed et
al., 2020;
Ferdaous
Albouchi et
al., 2018;
Ganesan et
al., 2018)
(Siddique et
al., 2020)
(Siddique et
al., 2020)
(Li et al.,
2018;
Siddique et
al., 2020)
(Chabir et al.,
2011;
Siddique et
al., 2017)
(Xu et al.,
2020)
(Yoshimura et
al., 2008)
(Goetz &
France, 2012)
(Hashim et
al., 2018)

II-Anti-malarial
M.armillaris

Essential oil

(Chabir et al.,
2011)

III- Cytotoxic, anti-tumor
M.armillaris

Essential oil

M. alternifolia

Tea tree oil

M.leucadendra

-Ethanolic extract of Leaves: myricetin 3-O-β-4
C1 -galactopyranuronoid
-Essential oil (1,8-cineole)

(Chabir et al.,
2011)
(Ali et al.,
2015)
(Hashim et
al., 2018;
Monzote et
al., 2020)

IV- Immunomodulator
M.alternifolia
M. quinquenervia

TTO (terpinene-4-ol)
Niaouli essential oil (1,8 cineole)

(Sandner et
al., 2020)
(Goetz &
France, 2012)

V-Antimycobacterial (tuberculosis)
M. cajuputi

Essential oil

(Bua et al.,
2020)

VI-Anti-Herpes virus
M. quinquenervia

Niaouli essential oil

M. styphelioides

Tellimagrandin I

(Goetz &
France, 2012)
(Treml et al.,
2020)

VII- Leshmanicidal
M.leucadendra

Essential oil (1,8-cineole)

https://digitalcommons.bau.edu.lb/hwbjournal/vol4/iss2/2
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3. DISCUSSION
The literature review on the pharmacology and phytochemistry of genus Melaleuca and
discussed previously revealed the potent antimicrobial effects of some species mainly M.
alternifolia which oil Tea tree oil (TTO) was reported in dermatologic and oral hygiene products
for its antimicrobial potential. But references showed that for minimum skin irritation, (TTO)
should contain a maximum of 15% cineol and a minimum of 30% terpineol(Wińska et al., 2019).
Furthermore, the most important species M. alternifolia was incorporated in many novel
techniques to benefit from its valuable oil (TTO), in addition to being granted patency for the
invention of William John Courtney, who invented a mixture of antimicrobial oils from M.
alternifolia and Leptospermum Scoparium (Singh et al., 2009). Besides the TTO and its derivatives
were also given the following patency EP1787652, US0195998, US0158127 for their antimycotic
potential (Shahid, 2016). Recently, to benefit from the therapeutic activities of this most promising
oil, and preventing its degradation by physicochemical processes, a new technique of delivery for
terpinen-4-ol the major component of TTO was adopted. It consists of liposomal formulations
incorporated in biomaterials, these new drug delivery systems are more thermostable than the oil
itself and exerts better effect (de Assis et al., 2020).Moreover Guanquan Lin prepared TTO
microspheres using styrene and butyl methacrylate monomers, with the help of divinyl benzene as
a crosslinking agent. This technique resulted in an increase in TTO stability and improvement in
its antibacterial effect (Lin et al., 2018).
The articles showed also that terpenoids present in most of Melaleuca species such as M.
styphelioides, M. Linarrifolia, M. fulgens, M. armillaris and M. bracteata proved very effective
against a large range of Gram-positive and Gram-negative bacteria, fungi, yeast. Thus, further
clinical studies are needed to prove that Genus Melaleuca is incredibly a promising plant within
the study of microbial resistance.
Each of the above-discussed pharmacological activities is related to a special bioactive
component in the Melaleuca species and specifically to the chemical structure or a specific ligand.
The structure activities relationship studies done, showed that the antimicrobial effect is related
mainly to the Phenolic -OH in the phytochemicals of the essential oil and hydrophobicity of
aromatic ring structure that contributes to the penetration and damaging of the microbe plasma
membrane(Konuk & Ergüden, 2020). Moreover, the inhibitory potential of M. cajuputi against
COVID-19 as assumed by the author is due to the phenolic OH in sesquiterpenes and
monoterpenes of the oil such as terpineol, guaiol, linalool, β-Selinenol, α-Eudesmol, and γEudesmol that bind to the amino acid in the PDB6LU7 protein in theSARS-CoV-2 (My et al.,
2020). So, advanced studies on this species are necessary to validate the inhibitory effect of M.
cajuputi against COVID-19 as well as the possibility of performing clinical studies on novel
molecules having the same ligand to prove this pharmacological effect.
Besides, the antioxidant potential is the result of structure-activity relationship such as the
antioxidant activities of Squarrosanin, A, B, and C tannins in M. squarrosa that may depend on
the conformation of the hydroxyl group at C-1 of the open ring d-glucose making the C-glucosidic
tannins more potent as radical scavengers than flavonoids (Kaneshima et al., 2016; Yoshimura et
al., 2008). Moreover, the presence of strongly activated methylene groups in the monoterpene
hydrocarbons present in the essential oil of some Melaleuca species is responsible for their
antioxidant potential such as α-terpinene, terpinolene and γ -Terpinene present in M. armillaris
(Chabir et al., 2011).
In addition, the cytotoxicity of M.leucadendra is mainly related to C2-C3-double bond,
aromatic ring-B at C-2, and hydroxy groups in ring-B in myricetin 3-O-β-4 C1 galactopyranuronoid present which is a novel flavonol glycoside isolated from this Melaleuca
species.(Hashim et al., 2018; Semwal et al., 2016)
Hopefully, based on the promising results collected in our manuscript, the phytochemicals
isolated from Melaleuca, may be the cornerstone in the area of clinical studies that should be done
on medicinal plants in parallel with adequate toxicity studies to guarantee the discovery of novel
safe and effective drugs.
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4. CONCLUSION
This review has been done for the first time on both volatile and non-volatile parts of plants
of genus Melaleuca. This work showed that this genus is rich in bioactive compounds mainly
sesquiterpenes, flavonoids, triterpenoids, phenols, and hydrolysable tannins, and might be a target
in drug manufacturing and development for the treatment of various diseases. Since most of the
studies were performed in vitro, further human trials on the phytoconstituents isolated versus
placebo are needed to validate the previous findings. Additional efforts are needed to incorporate
these bioactive compounds in the pharmaceutical industry and to widen the public understanding
of fruits and vegetable consumption containing them to benefit from their potentials in preventing
and treating hypertension, cancer, diabetes, and cardiovascular diseases. Moreover, the structureactivity relationship studies showed the importance of the phenolic OH- in the chemical structure
of most of the bioactive compounds in many Melaleuca species and this ligand is responsible for
the antiviral, antibacterial, antifungal, antioxidant, anti-inflammatory, and anti-leishmania
potential of the most promising species such as M. cajuputi, M. alternifolia, M. leucadendron, M.
styphelioides, M. squarrosa, M. armillaris, M. ercifolia, M. Linarrifolia, M. bracteata, and M.
fulgens.
Based on the results collected from the quantitative characteristics of Melaleuca constituents
it is possible to conclude the potent antimicrobial effect of Melaleuca extracts, so this plant can
help in the development of new antimicrobial molecules, and in the strategies adopted to
counteract the dangerous consequences of antibiotic resistance. But further researches are needed
to check its efficacy versus chemical drugs like the antimicrobial effect of the volatile oil extracted
versus antibiotics and more phytochemical studies are required in the future to determine the exact
mechanism of action and the structure-activity relation-ship of its diverse bioactive constituents.
Regulatory authorities within the world need to put more regulatory policies on herbal medicines
to assure the safety of those products since the conception about the safety of herbal drugs has to
be confirmed by further efficacy and toxicity studies.
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